NANOVIRICIDES, INC. · Drugmakers

NNVC

High riskNext report: Not enough history

View price ↗

The short version

A company still losing money, with high risk. Institutions are adding.

Going well

No debt reported

Watch out for

About 7 months of cash left at its current burn
Losing money, losses are large next to sales
Share count growing 9.4% a year

Money moves

No insider buying or selling in the last 30 days
Institutions added 25% to their holdings in the quarter ending June 2026 (18 bought, 14 sold)

Facts from SEC filings, not a recommendation.

The business over time

Last 12 quarters, from SEC filings

Profit, Jun '26 (worked out from yearly totals)

-$2.2M

Sep '23Tap a barJun '26

Last 12 months: -$8.2M.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

1/5Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.-88.2%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissProfitable every yearSteady profits, not one good year.0 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$8.5M
MissShare count not growingNot diluting owners. Falling means buybacks.+31.1% in 3 years

Total debt: None; 0.00x equity
Current ratio: 4.43x; short-term assets / bills due
Free cash flow: -$8.5M

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: net margin 10%+, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

EPS: -$0.10; vs -$0.13
Free cash flow: -$2.1M

Some values are worked out from year-to-date totals in the annual report.

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

50/ 100

This week: 1
Normal week: 1.0
vs normal: 1.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+24.8%

Institutions added 24.8% to their holdings. 18 bought, 14 sold.

Shares held by institutions2.4M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+29.9%

Cash runwayAt last year's cash burn

4 months

Debt to equityLatest balance sheet: debt compared with what owners have

No debt reported

Shares outstandingLatest reported

26M

Why high risk

Losing money, losses are large next to sales
About 4 months of cash left at its current burn
Share count growing 29.9% a year (dilution)
10 offering filings in 6 months (may sell new shares)

Earnings reports

Last 0

Next reportNot enough history

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Offering prospectusOct 21 · Form 424B5 ↗Proxy statementOct 8 · Form DEF 14A ↗Leadership changeSep 29 · Form 8-K ↗Annual reportSep 28 · Form 10-K ↗Offering prospectusSep 3 · Form 424B3 ↗EFFECTAug 31 · Form EFFECT ↗Shelf offering registrationAug 21 · Form S-3 ↗Major agreementJul 30 · Form 8-K ↗Offering prospectusJul 27 · Form 424B5 ↗Offering prospectusJul 27 · Form 424B5 ↗Offering prospectusJul 17 · Form 424B5 ↗Major agreementJul 17 · Form 8-K ↗Offering prospectusJul 1 · Form 424B3 ↗EFFECTJun 26 · Form EFFECT ↗CORRESPJun 23 · Form CORRESP ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page